Inscription à l’infolettre

Publications

Publications récentes

Voir les publications précédentes
  • 20 avril 2023

    The DynaSig-ML Python package: automated learning of biomolecular dynamics-function relationships.

    Mailhot O, Major F, Najmanovich R
    Bioinformatics 2023-04-20 ;

  • 8 avril 2023

    The Ubiquitination Status of the Glucagon Receptor determines Signal Bias.

    Kaur S, Sokrat B, Capozzi ME, El K, Bai Y, Jazic A, Han B, Krishnakumar K, D'Alessio DA, Campbell JE, Bouvier M, Shenoy SK
    J Biol Chem 2023-04-08 ;104690

  • 5 avril 2023

    Chronic hypoxia favours adoption to a castration-resistant cell state in prostate cancer.

    Cameron S, Deblois G, Hawley JR, Qamra A, Zhou S, Tonekaboni SAM, Murison A, Van Vliet R, Liu J, Locasale JW, Lupien M
    Oncogene 2023-04-05 ;

  • 1er avril 2023

    Rewiring of catecholamine-induced calcium signalling is an early event in non-alcoholic fatty liver disease.

    Wright SC, Lauschke VM
    J Physiol 2023-04-01 ;601( 8 ):1317-1318

  • 1er avril 2023

    Pulmonary artery banding in sheep: a novel large animal model for congestive hepatopathy.

    Ukita R, Wu WK, Liang J, Talackine JR, Patel YJ, Francois SA, Cardwell NL, Flynn CR, Shingina A, Washington MK, Trinh VQ, Bacchetta M, Alexopoulos SP
    J Appl Physiol (1985) 2023-04-01 ;134( 4 ):840-845

  • 30 mars 2023

    Xenogeneic cross-circulation for physiologic support and recovery of ex vivo human livers.

    Wu WK, Ukita R, Patel YJ, Cortelli M, Trinh VQ, Ziogas IA, Francois SA, Mentz M, Cardwell NL, Talackine JR, Grogan WM, Stokes JW, Lee YA, Kim J, Alexopoulos SP, Bacchetta M
    Hepatology 2023-03-30 ;

  • 24 mars 2023

    OpenCustomDB: Integration of Unannotated Open Reading Frames and Genetic Variants to Generate More Comprehensive Customized Protein Databases.

    Guilloy N, Brunet MA, Leblanc S, Jacques JF, Hardy MP, Ehx G, Lanoix J, Thibault P, Perreault C, Roucou X
    J Proteome Res 2023-03-24 ;

  • 23 mars 2023

    Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabine.

    Assouline S, Gasiorek J, Bergeron J, Lambert C, Culjkovic-Kraljacic B, Cocolakis E, Zakaria C, Szlachtycz D, Yee K, Borden K
    Haematologica 2023-03-23 ;

Voir plus de publications